Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The evolving promise of Genomic medicine

902 views

Published on

Today, a mix of influences - including innovation in biology and technology, market demand and consumerism - is furthering a genomic medicine evolution that crosses industries.
To benefit from the far-reaching industry transformation that has begun, forward-thinking executives can: verify that genomic medicine is part of their enterprise vision and strategy; assess and plan to fill existing and future skill gaps; and look closely at how and when partnering will help their organizations succeed in meeting stakeholder needs.

Published in: Healthcare
  • Be the first to comment

The evolving promise of Genomic medicine

  1. 1. The evolving promise of genomic medicine IBM Institute for Business Value Exploring major changes ahead from genomic medicine © Copyright IBM Corporation 2014. IBM, the IBM logo and ibm.com are trademarks or registered trademarks of IBM Corp., registered in many jurisdictions worldwide. Other product or service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.shtml 2001 2003 2014 Innovation in biology and technology Growing market demand for targeted products Consumerism and regulatory attention bring new media attention Genomic medicine and technology improvements offer substantial benefits Data analytics will include cognitive computing platforms Achieve insights on with high efficacy and low side effects Share and validate insights among communities Offer faster “second opinions” with higher confidence and rigor Disease progression models will guide physicians Oncology is expected to benefit first Translational medicine Personalized healthcare Sequencing Becomes faster, cheaper and more accurate Aggregate and analyze information from multiple sources Analytics capabilities increase raw data's value The growing use of a new genomic health record Opportunities for radical industry transformation across healthcare and life sciences Greater benefits for stakeholders Announcement of Human Genome Project Human Genome Project declared complete 2000 2005 2010 2015 Register to read this report: http://bit.ly/genomicpaper GBL03022-USEN-00

×